MedDataX Logo

Non-Interventional Study Of Celsentri® In Treatment Experienced Patients With CCR5-Tropic HIV-Infection

NCT ID: NCT00850395

Last Updated: 2012-11-07

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

79 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-07-31

Study Completion Date

2011-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Aim of the study is to gain more knowledge about efficacy of CELSENTRI® in daily clinical practice and obtain information about the quality of life of patients using CELSENTRI®.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Non interventional study, inclusion and exclusion criteria defined by the labelling of Celsentri (Maraviroc).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV-1

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

HIV-1 non-interventional CCR-5 tropic virus therapy experienced patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Non-Interventional

maraviroc

Intervention Type DRUG

No intervention; any procedure at the discretion of the treating physician, in line with the SmPC

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

maraviroc

No intervention; any procedure at the discretion of the treating physician, in line with the SmPC

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Selzentry, Celsentri

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

HIV-1 infection. CCR-5 tropic virus. Therapy experienced patient,

Exclusion Criteria

X4 or D/M tropic virus. Therapy-naive patients.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pfizer

INDUSTRY

Sponsor Role collaborator

ViiV Healthcare

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pfizer CT.gov Call Center

Role: STUDY_DIRECTOR

Pfizer

Related Links

Access external resources that provide additional context or updates about the study.

https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A4001070&StudyName=Non-Interventional%20Study%20Of%20Celsentri%AE%20In%20Treatment%20Experienced%20Patients%20With%20CCR5-Tropic%20HIV-Infection

To obtain contact information for a study center near you, click here.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CELTROP

Identifier Type: -

Identifier Source: secondary_id

A4001070

Identifier Type: -

Identifier Source: org_study_id